Response of cochlear blood flow to prostaglandin E₁ applied topically to the round window

References

• Nakashima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H, et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 2003; 43: 17–28
   PubMed Web of Science ®Google Scholar
• Ney P, Braun M, Szymanski C, Bruch L, Schror K. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)—an in vivo metabolite of PGE1 in man. Eicosanoids 1991; 4: 177–84
   PubMedGoogle Scholar
• Itoh Y, Yasui T, Kakizawa H, Makino M, Fujiwara K, Kato T, et al. The therapeutic effect of lipo PGE1 on diabetic neuropathy—changes in endothelin and various angiopathic factors. Prostaglandins Other Lipid Mediat 2001; 66: 221–34
   PubMedGoogle Scholar
• Nakashima T, Kuno K, Yanagita N. Evaluation of prostaglandin E1 therapy for sudden deafness. Laryngoscope 1989; 99: 542–6
   PubMed Web of Science ®Google Scholar
• Ogawa K, Takei S, Inoue Y, Kanzaki J. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol 2002; 23: 665–8
   PubMed Web of Science ®Google Scholar
• Kanzaki J, Inoue Y, Ogawa K, Fukuda S, Fukushima K, Gyo K, et al. Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2003; 30: 123–7
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Tominaga M, Sone M, Nakashima T. Contribution of stapedial artery to blood flow in the cochlea and its surrounding bone. Hear Res 2003; 186: 69–74
   PubMedGoogle Scholar
• Tien HC, Linthicum FH, Jr. Persistent stapedial artery. Otol Neurotol 2001; 22: 975–6
   PubMedGoogle Scholar
• Hogg ID, Stephens CB, Arnold GE. Theoretical anomalies of the stapedial artery. Ann Otol Rhinol Laryngol 1972; 81: 860–70
   PubMedGoogle Scholar
• Govaerts PJ, Marquet TF, Cremers WR, Offeciers FE. Persistent stapedial artery: does it prevent successful surgery?. Ann Otol Rhinol Laryngol 1993; 102: 724–8
   PubMedGoogle Scholar
• Davies DG. Persistent stapedial artery: a temporal bone report. J Laryngol Otol 1967; 81: 649–60
   PubMedGoogle Scholar
• Steffen TN. Vascular anomalies of the middle ear. Laryngoscope 1968; 78: 171–97
   PubMedGoogle Scholar
• Moreano EH, Paparella MM, Zelterman D, Goycoolea MV. Prevalence of facial canal dehiscence and of persistent stapedial artery in the human middle ear: a report of 1000 temporal bones. Laryngoscope 1994; 104: 309–20
   PubMed Web of Science ®Google Scholar
• Ohlsén KA, Baldwin DL, Nuttall AL, Miller JM. Influence of topically applied adrenergic agents on cochlear blood flow. Circ Res 1991; 69: 509–18
   PubMed Web of Science ®Google Scholar
• Miller JM, Laurikainen EA, Grenman RA, Suonpaa G, Bredberg G. Epinephrine-induced changes in human cochlear blood flow. Am J Otol 1994; 15: 299–305
   PubMedGoogle Scholar
• Ohlsén KA, Didier A, Baldwin D, Miller JM, Nuttall AL, Hultcrantz E. Cochlear blood flow in response to dilating agents. Hear Res 1992; 58: 19–25
   PubMed Web of Science ®Google Scholar
• Nakashima T, Nuttall AL, Miller JM. Effects of vasodilating agents on cochlear blood flow in mice. Hear Res 1994; 80: 241–6
   PubMed Web of Science ®Google Scholar
• Ito A, Nakashima T, Yanagita N. Effect of topical application of nitroglycerin on cochlear blood flow. Am J Otolaryngol 1995; 16: 177–80
   PubMedGoogle Scholar
• Sone M, Hayashi H, Yamamoto H, Tominaga M, Nakashima T. A comparative study of intratympanic steroid and NO synthase inhibitor for treatment of cochlear lateral wall damage due to acute otitis media. Eur J Pharmacol 2003; 482: 313–8
   PubMed Web of Science ®Google Scholar
• Rhee CK, Park YS, Jung TT, Park CI. Effects of leukotrienes and prostaglandins on cochlear blood flow in the chinchilla. Eur Arch Otorhinolaryngol 1999; 256: 479–83
   PubMed Web of Science ®Google Scholar
• Laurikainen E, Miller JF, Pyykko I. Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl 2000; 544: 5–7
   PubMedGoogle Scholar
• Vass Z, Brechtelsbauer PB, Nuttall AL, Miller JM. Nitric oxide mediates capsaicin-induced increase in cochlear blood flow. Hear Res 1996; 100: 114–9
   PubMed Web of Science ®Google Scholar
• Brechtelsbauer PB, Nuttall AL, Miller JM. Basal nitric oxide production in regulation of cochlear blood flow. Hear Res 1994; 77: 38–42
   PubMed Web of Science ®Google Scholar
• Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998; 19: 230–5
   PubMedGoogle Scholar
• Shivapuja BG, Gu ZP, Saunders SS, Quirk WS. Acute effects of cocaine on cochlear function. Hear Res 1993; 69: 243–50
   PubMed Web of Science ®Google Scholar
• Vass Z, Nuttall AL, Coleman JK, Miller JM. Capsaicin-induced release of substance P increases cochlear blood flow in the guinea pig. Hear Res 1995; 89: 86–92
   PubMedGoogle Scholar
• Kong WJ, Ren T, Nuttall AL. Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside. Hear Res 1996; 99: 22–30
   PubMed Web of Science ®Google Scholar
• Nishimura T, Nario K, Hosoi H. Effects of intravenous administration of prostaglandin E1 and lipo-prostaglandin E1 on cochlear blood flow in guinea pigs. Eur Arch Otorhinolaryngol 2002; 259: 253–6
   PubMedGoogle Scholar
• Nagahara K, Aoyama T, Fukuse S, Noi O. Effects of prostaglandins on perilymphatic oxygenation. Enhancement of cochlear autoregulation by prostacyclin. Acta Otolaryngol Suppl (Stockh) 1988; 456: 143–50
   PubMedGoogle Scholar
• Miller JM, Brown JN, Schacht J. 8-iso-prostaglandin F2α, a product of noise exposure, reduces inner ear blood flow. Audiol Neurootol 2003; 8: 207–21
   PubMed Web of Science ®Google Scholar
• Rask-Andersen, H, Friberg, U, Johansson, M, Stjernschantz, J. Effects of intratympanic injection of latanoprost in Ménière's disease: a randomized, placebo-controlled, double-blind, pilot study. Otolaryngol Head Neck Surg 2005; 133: 44–3.
   Google Scholar